- Newborn Hearing Screening Instruments
- Newborn Disorder Screening Instruments
- Hearing Screening Accessories
- Hearing Screening Devices
- Pulse Oximeters
- Reagents and Assay Kits
Newborn Screening Market size was valued at USD 838 million in 2021 and is expected to reach USD 1666.2 million by 2028, at a CAGR of 7.9% during the forecast period 2022 to 2028. Newborn screening is the practice where every newborn baby is tested for certain potentially fatal disorders. As newborns are more liable to infections, newborn screening helps in early diagnosis and proper treatment which can make the difference between lifelong impairment and healthy development. Newborn screening consists of a blood test, hearing screening, and screening for critical congenital heart defects. The screening is done within few days of birth. These screening programs are generally run by state or national governing bodies. In this program, various initiatives have been taken by the Japanâ€™s Society of Obstetrics and Gynecology (JSOG), UK (PEACH), and U.S. Department of Health and Human Services Secretaryâ€™s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC). WHO recommended the newborn screening program in order to safeguard the health of children all over the world. Newborn screening not only saves lives but can also improve the health of the children. The World Health Organization has stated that over 270,000 babies globally die of congenital disorders. In 2010, the WHO has taken a step in order to resolve the neonatal deaths by developing strong surveillance systems. It is reported that more than 2.8 million babies die within the first month due to improper care and screening of the babies. In order to prevent these deaths WHO, Healthy Newborn Network, etc., has taken efforts to bring awareness by educating the parents about the neonatal disorders and the process of safeguarding the health of children. Key Developments: In February 2018, Sema4, a health information company providing advanced genomic testing, announced the launch of Sema4 Natalis, a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders so parents can gain insight into their babyâ€™s health.
Fastest Growing Market
The newborn screening market is driven rising neonatal population and the increase in incidence of neonatal diseases. Growing awareness regarding neonatal diseases owing to government and non-government bodiesâ€™ campaigns that in turn drive the market growth positively. Funding from government is also frosting the market growth. However, the unavailability of advanced instruments, delays in hospitalization, and high cost of automation technology may restrain the global newborn screening market growth.
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.